Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
Current Opinion in Pharmacology
|
August 18, 2009
FGFs and metabolism
Alexei Kharitonenkov
Trends in Endocrinology and Metabolism: TEM
|
October 23, 2015
FGF21 Revolutions: Recent Advances Illuminating FGF21 Biology and Medicinal Properties
Alexei Kharitonenkov, Richard DiMarchi
Cell Metabolism
|
October 9, 2014
Break on through to the other 1
Alexei Kharitonenkov, Richard DiMarchi
Trends in Endocrinology and Metabolism: TEM
|
January 4, 2011
FGF21 reloaded: challenges of a rapidly growing field
Alexei Kharitonenkov, Philip Larsen
Molecular Metabolism
|
December 31, 2020
FGF19 and FGF21: In NASH we trust
Saswata Talukdar, Alexei Kharitonenkov
Current Opinion in Investigational Drugs (London, England : 2000)
|
April 2, 2009
FGF21: a novel prospect for the treatment of metabolic diseases
Alexei Kharitonenkov, Armen B Shanafelt
Biochimica Et Biophysica Acta
|
April 21, 2011
Hormone-like fibroblast growth factors and metabolic regulation
Yun Chau Long, Alexei Kharitonenkov
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
January 25, 2008
Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases
Alexei Kharitonenkov, Armen B Shanafelt
Molecular Metabolism
|
April 22, 2014
Inventing new medicines: The FGF21 story
Alexei Kharitonenkov, Andrew C Adams
Advances in Experimental Medicine and Biology
|
March 8, 2012
FGF21 as a therapeutic reagent
Yang Zhao, James D Dunbar, Alexei Kharitonenkov
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
Current Opinion in Pharmacology
|
August 18, 2009
FGFs and metabolism
Alexei Kharitonenkov
Trends in Endocrinology and Metabolism: TEM
|
October 23, 2015
FGF21 Revolutions: Recent Advances Illuminating FGF21 Biology and Medicinal Properties
Alexei Kharitonenkov, Richard DiMarchi
Cell Metabolism
|
October 9, 2014
Break on through to the other 1
Alexei Kharitonenkov, Richard DiMarchi
Trends in Endocrinology and Metabolism: TEM
|
January 4, 2011
FGF21 reloaded: challenges of a rapidly growing field
Alexei Kharitonenkov, Philip Larsen
Molecular Metabolism
|
December 31, 2020
FGF19 and FGF21: In NASH we trust
Saswata Talukdar, Alexei Kharitonenkov
Current Opinion in Investigational Drugs (London, England : 2000)
|
April 2, 2009
FGF21: a novel prospect for the treatment of metabolic diseases
Alexei Kharitonenkov, Armen B Shanafelt
Biochimica Et Biophysica Acta
|
April 21, 2011
Hormone-like fibroblast growth factors and metabolic regulation
Yun Chau Long, Alexei Kharitonenkov
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
January 25, 2008
Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases
Alexei Kharitonenkov, Armen B Shanafelt
Molecular Metabolism
|
April 22, 2014
Inventing new medicines: The FGF21 story
Alexei Kharitonenkov, Andrew C Adams
Advances in Experimental Medicine and Biology
|
March 8, 2012
FGF21 as a therapeutic reagent
Yang Zhao, James D Dunbar, Alexei Kharitonenkov
Page
of 7